Biosensors, Aptamers & measuring molecules in real-time - Peter Vranes Reimagining Healthcare
-
- Health & Fitness
Peter Vranes is a Co-founder of Nutromics, an Australian med-tech company providing continuous, real-time molecular monitoring using a smart patch biosensor platform. In this episode, Peter shares his story from having already built and exited a successful cosmeceutical brand and how that led to meeting his co-founder to build Nutromics. He also talks about how that experience led to them participating in a med-tech accelerator, and their journey through capital raising and biosensor supported proof of concepts.
Key takeaways:
Conventional molecular tests and monitoring leaves big gaps in terms of the information needed to support decision making (especially where monitoring of fast-moving molecular targets is needed), biosensors are set to revolutionize healthcare.
Nutromics has developed a one patch platform that can be adapted to many applications and can ensure, continuously and in real-time, that a patient is receiving a dose at the right time and level to stay within the therapeutic range.
The molecular biosensing technology has a microneedle array platform and an aptamer sensor platform that promises flexibility for this Smart Patch to be used in many different therapeutic contexts.
Resources and links:
https://www.linkedin.com/in/peter-vranes-085bb810/
https://www.nutromics.com.au/
Connect:
Listen to other episodes of Reimagining Healthcare
Connect with Yianni Serpanos on LinkedIn
Follow HealthTechX on LinkedIn
Follow HealthTechX on Instagram
Follow HealthTechX on Meetup
LinkedIn Company Page: https://www.linkedin.com/company/healthtechx/
See omnystudio.com/listener for privacy information.
Peter Vranes is a Co-founder of Nutromics, an Australian med-tech company providing continuous, real-time molecular monitoring using a smart patch biosensor platform. In this episode, Peter shares his story from having already built and exited a successful cosmeceutical brand and how that led to meeting his co-founder to build Nutromics. He also talks about how that experience led to them participating in a med-tech accelerator, and their journey through capital raising and biosensor supported proof of concepts.
Key takeaways:
Conventional molecular tests and monitoring leaves big gaps in terms of the information needed to support decision making (especially where monitoring of fast-moving molecular targets is needed), biosensors are set to revolutionize healthcare.
Nutromics has developed a one patch platform that can be adapted to many applications and can ensure, continuously and in real-time, that a patient is receiving a dose at the right time and level to stay within the therapeutic range.
The molecular biosensing technology has a microneedle array platform and an aptamer sensor platform that promises flexibility for this Smart Patch to be used in many different therapeutic contexts.
Resources and links:
https://www.linkedin.com/in/peter-vranes-085bb810/
https://www.nutromics.com.au/
Connect:
Listen to other episodes of Reimagining Healthcare
Connect with Yianni Serpanos on LinkedIn
Follow HealthTechX on LinkedIn
Follow HealthTechX on Instagram
Follow HealthTechX on Meetup
LinkedIn Company Page: https://www.linkedin.com/company/healthtechx/
See omnystudio.com/listener for privacy information.
51 min